Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of undruggable diseases.
Feature
A news update about the Magnificent Microbes event featuring a weeklong programme of activities that could be done in schools, with a ‘scientist Q&A’ via Teams video at the end of the week to wrap everything up.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
News
Our green space provides an educational resource to learn both about the history of medicines, as well as the ground-breaking drug discovery work going on inside our building.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.
News
The School of Life Sciences has been awarded a prestigious Gold Watermark for its work in bringing world-class science to the wider community.
News
Evotec invests in Exscientia to advance AI-driven drug discovery
News
A new diagnostic test developed from research at the Universities of Dundee and Cambridge has been launched with the aim of helping eliminate the disease known as African sleeping sickness.
News
Pre-clinical collaboration focused on up to 10 targets nominated by GSK